Literature DB >> 26667886

Global Cancer Incidence and Mortality Rates and Trends--An Update.

Lindsey A Torre1, Rebecca L Siegel2, Elizabeth M Ward3, Ahmedin Jemal2.   

Abstract

There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for 2003-2007. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26667886     DOI: 10.1158/1055-9965.EPI-15-0578

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  1040 in total

1.  Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician Interviews.

Authors:  Stefan Holmstrom; Shevani Naidoo; James Turnbull; Emily Hawryluk; Jean Paty; Robert Morlock
Journal:  Patient       Date:  2019-02       Impact factor: 3.883

2.  Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity.

Authors:  Huda H Al-Khalaf; Mrad Amir; Falah Al-Mohanna; Asma Tulbah; Adher Al-Sayed; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

3.  Comparison between the impact of fermented and unfermented soy intake on the risk of liver cancer: the JPHC Study.

Authors:  Sarah Krull Abe; Norie Sawada; Junko Ishihara; Ribeka Takachi; Nagisa Mori; Taiki Yamaji; Taichi Shimazu; Atsushi Goto; Motoki Iwasaki; Manami Inoue; Shoichiro Tsugane
Journal:  Eur J Nutr       Date:  2020-07-27       Impact factor: 5.614

4.  Can Proximal Gastrectomy with Double-Tract Reconstruction Replace Total Gastrectomy? A Propensity Score Matching Analysis.

Authors:  Hyo Jung Ko; Ki Hyun Kim; Si-Hak Lee; Cheol Woong Choi; Su Jin Kim; Chang In Choi; Dae-Hwan Kim; Dong-Heon Kim; Sun-Hwi Hwang
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

Review 5.  Virus-Derived Peptides for Clinical Applications.

Authors:  Mingying Yang; Kegan Sunderland; Chuanbin Mao
Journal:  Chem Rev       Date:  2017-07-19       Impact factor: 60.622

6.  Large-scale DNA organization is a prognostic marker of breast cancer survival.

Authors:  Martial Guillaud; Qian Ye; Sam Leung; Anita Carraro; Alan Harrison; Malcolm Hayes; Alan Nichol; Mira Keyes
Journal:  Med Oncol       Date:  2017-12-06       Impact factor: 3.064

7.  Particulate Matter and Traffic-Related Exposures in Relation to Breast Cancer Survival.

Authors:  Natalie C DuPré; Jaime E Hart; Michelle D Holmes; Elizabeth M Poole; Peter James; Peter Kraft; Francine Laden; Rulla M Tamimi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-15       Impact factor: 4.254

8.  Red meat and processed meat intake and risk of colorectal cancer: a population-based case-control study.

Authors:  Walid Saliba; Hedy S Rennert; Naomi Gronich; Stephen B Gruber; Gad Rennert
Journal:  Eur J Cancer Prev       Date:  2019-07       Impact factor: 2.497

9.  Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages.

Authors:  Carlos Moctezuma-Velazquez; Aldo J Montano-Loza; Judith Meza-Junco; Kelly Burak; Mang Ma; Vincent G Bain; Norman Kneteman; Phillipe Sarlieve; Richard J Owen
Journal:  Dig Dis Sci       Date:  2020-04-12       Impact factor: 3.199

10.  Serum miR-182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats.

Authors:  Merricka C Livingstone; Natalie M Johnson; Bill D Roebuck; Thomas W Kensler; John D Groopman
Journal:  Mol Carcinog       Date:  2019-08-02       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.